| GRANULES INDIA LIMITED | |||||||
| Regd Office : 2nd Floor, 3rd Block, My Home Hub | |||||||
| Madhapur, Hyderabad 500 081 | |||||||
| UNAUDITED FINANCIAL RESULTS | |||||||
| FOR THE QUARTER ENDED 30th SEPTEMBER, 2008 | |||||||
| Rs. Lakhs | |||||||
| S No | Particulars | 3 months ended 30th Sept, 2008 | Corresponding 3 months ended in the previous year 30th Sept, 2007 | Previous accounting year ended 30th June, 2008 | |||
| Unaudited | Unaudited | Audited | |||||
| 1 | Net sales / Income from Operations | 8,144.60 | 5,003.06 | 21,414.65 | |||
| 2 | Expenditure | ||||||
| a) (Increase)/decrease in stocks & work in progress | (517.09) | (54.11) | (869.25) | ||||
| b) Consumption of Raw Materials | 5,756.33 | 2,932.56 | 13,347.33 | ||||
| c) Manufacturing Expenses | 510.21 | 398.86 | 1,756.77 | ||||
| d) Employee cost | 403.25 | 353.15 | 1,389.97 | ||||
| e) Administrative Expenses | 259.33 | 188.75 | 837.04 | ||||
| f) Foreign Exchange Fluctuations | 245.72 | 42.83 | 22.63 | ||||
| g) Selling & Distribution Expenses | 491.29 | 369.43 | 1,501.67 | ||||
| h) Depreciation | 259.84 | 232.47 | 972.09 | ||||
| i) Other expenditure | 9.40 | 3.41 | 46.56 | ||||
| Total | 7,418.28 | 4,467.36 | 19,004.82 | ||||
| 3 | Other Income | (19.09) | (8.17) | (68.51) | |||
| 4 | Interest and Bank charges | 391.07 | 268.49 | 1,197.22 | |||
| 5 | Profit before taxation | 354.34 | 275.38 | 1,281.12 | |||
| 6 | Tax expense | ||||||
| Current Tax Expense | 40.15 | 26.14 | 145.15 | ||||
| Deferred Tax Expense | 36.79 | 44.68 | 210.85 | ||||
| Fringe Benefit Tax | 3.23 | 2.66 | 11.70 | ||||
| 7 | Net Profit | 274.17 | 201.90 | 913.42 | |||
| 8 | Paid-up share capital (Face Value of Rs.10/- each) | 2,005.72 | 2,004.11 | 2,005.72 | |||
| 9 | Reserves excluding Revaluation Reserve | - | - | 15,894.21 | |||
| 10 | Earning Per Share (EPS) | ||||||
| Basic Earnings per share (Rs.)* | 1.37 | 1.01 | 4.55 | ||||
| 11 | Public Shareholding | ||||||
| - No. of shares | 12,644,517 | 13,688,103 | 13,547,423 | ||||
| - Percentage of shareholding | 63.04% | 68.30% | 67.54% | ||||
| * Not Annualised for quarter ending | |||||||
| NOTES : | |||||||
| 1) The above results were reviewed by the Audit Committee and approved by the Board at its meeting held on | |||||||
| 20th October, 2008 and were subjected to limited review by Statutory Auditors. | |||||||
| 2) Tablet division had commenced commercial operations from 23rd September, 2008. | |||||||
| 3) Foreign Exchange Fluctuations of Rs.245.72 lakhs (net) includes re-statement of foreign currency loans, | |||||||
| receivables and payables. | |||||||
| 4) 16,00,000 share warrants issued have lapsed on 27th September, 2008 and hence forfeited. | |||||||
| 5) The above unaudited results are for the single entity and do not include consolidated financials | |||||||
| 6) The company has not received any complaints from investors during the quarter 1st July '08 to 30th Sept '08 | |||||||
| and no complaints were pending from previous quarter. | |||||||
| 7) The Company operates only in the segment of Pharmaceuticals. | |||||||
| 8) Figures are regrouped wherever necessary. | |||||||
| for and on behalf of the board | |||||||
| Place : Hyderabad | Dr.C.Nageswara Rao | ||||||
| Date : 20.10.2008 | Chairman | ||||||